Boiron SA (EPA:BOI)

Market Cap	399.33M
Revenue (ttm)	487.56M
Net Income (ttm)	11.34M
Shares Out	17.36M
EPS (ttm)	0.65
PE Ratio	35.23
Forward PE	14.74
Dividend	1.20 (5.22%)
Ex-Dividend Date	Jun 3, 2025

Volume	215
Average Volume	2,250
Open	23.00
Previous Close	23.00
Day's Range	22.75 - 23.00
52-Week Range	22.65 - 34.30
Beta	0.23
RSI	37.77
Earnings Date	Jul 18, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: Euronext Paris
• Ticker Symbol: BOI

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.